文献速递儿科与产科急症消化、代谢与肾脏急症重症综合管理与镇静镇痛

妊娠急性脂肪肝与HELLP综合征临床特征比较

[A comparison of clinical characteristics between acute fatty liver of pregnancy and hemolysis, elevated liver enzymes and low platelets syndrome].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论妊娠急性脂肪肝与HELLP综合征在临床特征、实验室指标及并发症上差异显著,TBil、γ-GGT、SCr、FIB、INR和AT Ⅲ活性可能有助于鉴别。

该回顾性队列研究纳入2016年1月至2021年12月云南省三家三级转诊中心的13例妊娠急性脂肪肝(AFLP)和34例HELLP综合征患者,分别按Swansea标准和Tennessee分类系统诊断,比较入院24小时内临床特征、实验室结果、并发症及母婴结局。AFLP组BMI和血压更低(均P<0.01);PLT、TBil、DBil、γ-GGT、ALP、TBA、SCr、INR显著升高,PT显著延长,GLU、FIB、AT Ⅲ活性显著降低(均P<0.05)。AFLP组低血糖、急性肝衰竭、急性肾功能不全、凝血病、DIC、MODS发生率更高(均P<0.05),住院和ICU停留时间更长(均P<0.01),2例死亡,HELLP组无死亡。结论提示部分实验室指标可能有助于鉴别两种疾病。

要点

  • 与HELLP组相比,AFLP组TBil、γ-GGT、SCr、INR显著升高而FIB、AT Ⅲ活性显著降低,可能有助于鉴别。
  • AFLP组急性肝衰竭、DIC、MODS发生率均显著高于HELLP组(均为53.85% vs 5.88%,P<0.05)。
  • AFLP组低血糖发生率30.77%(4/13)vs HELLP组0%(0/34),急性肾功能不全69.23%(9/13)vs 8.82%(3/34),均P<0.05。
  • AFLP组住院和ICU停留时间显著长于HELLP组[17.00(11.00, 25.00)天 vs 9.00(7.00, 12.00)天;12.00(4.00, 22.00)天 vs 3.91(0, 7.00)天,均P<0.01]。
  • AFLP组2例死亡(颅内静脉血栓1例,多器官衰竭合并心肺骤停1例),HELLP组无死亡。

适用人群与场景

  • 2016年1月至2021年12月云南省三家三级转诊中心收治的13例AFLP和34例HELLP综合征患者。
  • AFLP按Swansea标准诊断,HELLP综合征按Tennessee分类系统诊断。

诊断标准与关键阈值

  • AFLP诊断标准:Swansea标准。
  • HELLP综合征诊断标准:Tennessee分类系统。

红旗征与不能漏的情况

  • AFLP组低血糖发生率30.77%(4/13)vs HELLP组0%(0/34),P<0.05。
  • AFLP组急性肝衰竭发生率53.85%(7/13)vs HELLP组5.88%(2/34),P<0.05。
  • AFLP组急性肾功能不全发生率69.23%(9/13)vs HELLP组8.82%(3/34),P<0.05。
  • AFLP组凝血病发生率76.92%(10/13)vs HELLP组38.24%(13/34),P<0.05。
  • AFLP组DIC发生率53.85%(7/13)vs HELLP组5.88%(2/34),P<0.05。
  • AFLP组MODS发生率53.85%(7/13)vs HELLP组5.88%(2/34),P<0.05。

研究设计与关键结果

  • 研究类型:回顾性队列研究,纳入13例AFLP和34例HELLP综合征患者,来自云南省三家三级转诊中心。
  • 与HELLP组相比,AFLP组入院时BMI和血压更低(均P<0.01)。
  • AFLP组最常见症状为皮肤黄疸、腹痛、恶心呕吐、水肿;HELLP组主要表现蛋白尿、高血压、水肿、头痛。
  • 入院24小时内AFLP组vs HELLP组:PLT(×10⁹/L)107.69±51.13 vs 76.71±43.25;TBil(μmol/L)121.60(83.20,170.00)vs 15.25(7.22,29.05);DBil(μmol/L)86.50(58.60,104.00)vs 4.30(2.22,10.10);γ-GGT(U/L)87.00(37.00,127.00)vs 41.00(19.00,64.42);ALP(U/L)199.10(109.00,349.20)vs 125.50(90.50,155.25);TBA(μmol/L)51.50(16.20,117.40)vs 4.15(2.02,6.95);SCr(μmol/L)155.80(129.00,237.00)vs 79.00(65.43,113.70);
  • 入院24小时内AFLP组vs HELLP组:GLU(mmol/L)5.18±1.33 vs 6.33±1.19;FIB(g/L)1.96±1.46 vs 3.81±1.58;AT Ⅲ(%)40.61±25.84 vs 66.39±24.11;均P<0.05。
  • 所有患者入院后均分娩;AFLP组总住院时间和ICU停留时间显著长于HELLP组[17.00(11.00,25.00)天 vs 9.00(7.00,12.00)天;12.00(4.00,22.00)天 vs 3.91(0,7.00)天,均P<0.01]。
  • AFLP组2例死亡(颅内静脉血栓1例,多器官衰竭合并心肺骤停1例),HELLP组无死亡。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为TBil、γ-GGT、SCr、FIB、INR和AT Ⅲ活性可能有助于鉴别AFLP与HELLP综合征。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare and analyze the clinical characteristics between acute fatty liver of pregnancy (AFLP) and the hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.

METHODS: This is a retrospective cohort study. The clinical data of 13 cases with AFLP and 34 cases with HELLP syndrome were collected from three tertiary referral centers in Yunnan (the First Affiliated Hospital of Kunming Medical University, the Second Affiliated Hospital of Kunming Medical University, and Yan'an Hospital of Kunming City) from January 2016 to December 2021. The patients were diagnosed to AFLP and HELLP syndrome according to the Swansea criteria and the Tennessee classification system. The general characteristics, clinical features, laboratory results within 24 hours after admission, complications, maternal and neonatal outcomes were compared to analysis the differences between the two groups.

RESULTS: (1) Maternal characteristics: compared with HELLP syndrome group, AFLP group had lower body mass index (BMI) and blood pressure at admission (both P < 0.01). (2) Clinical features: the most common symptoms in AFLP patients were skin jaundice, abdominal pain, nausea and vomiting, edema. The main manifestations of patients with HELLP syndrome were albuminuria, hypertension, edema, headache. Some patients had multiple symptoms concurrently. (3) Laboratory results: compared with HELLP syndrome group, the levels of platelet count (PLT), total bilirubin (TBil), direct bilirubin (DBil), γ-glutamyl transferase (γ-GGT), alkaline phosphatase (ALP), total bile acid (TBA), serum creatinine (SCr) and international standardized ratio (INR) in AFLP group were significantly increased within 24 hours after admission [PLT (×109/L): 107.69±51.13 vs.76.71±43.25,TBil (μmol/L): 121.60 (83.20, 170.00) vs.15.25 (7.22, 29.05), DBil (μmol/L): 86.50 (58.60, 104.00) vs. 4.30 (2.22,10.10), γ-GGT (U/L): 87.00 (37.00, 127.00) vs. 41.00 (19.00,64.42), ALP (U/L): 199.10 (109.00, 349.20) vs. 125.50 (90.50, 155.25), TBA (μmol/L): 51.50 (16.20, 117.40) vs. 4.15 (2.02, 6.95), SCr (μmol/L): 155.80 (129.00, 237.00) vs. 79.00 (65.43, 113.70), INR: 1.28 (1.17, 1.63) vs. 0.94 (0.88, 1.08), all P < 0.05], prothrombin time (PT) was significantly prolonged [seconds: 16.10 (14.50, 19.20) vs. 12.40 (11.43, 13.40), P < 0.05]. The level of blood glucose (GLU), fibrinogen (FIB) and the activity of antithrombin III (AT III) decreased significantly [GLU (mmol/L): 5.18±1.33 vs. 6.33±1.19, FIB (g/L): 1.96±1.46 vs. 3.81±1.58, AT III (%): 40.61±25.84 vs. 66.39±24.11, all P < 0.05]; (4) Complications: compared with HELLP syndrome group, the incidence of patients with hypoglycemia [30.77% (4/13) vs. 0% (0/34)], acute liver failure [53.85% (7/13) vs. 5.88% (2/34)], acute renal insufficiency [69.23% (9/13) vs. 8.82% (3/34)], coagulopathy [76.92% (10/13) vs. 38.24% (13/34)], disseminated intravascular coagulation (DIC) [53.85% (7/13) vs. 5.88% (2/34)], and multiple organ dysfunction syndrome (MODS) [53.85% (7/13) vs. 5.88% (2/34)] were significantly higher in AFLP group (all P <0.05). (5) Maternal and neonatal outcome: all patients delivered after admission. The total length of hospital and intensive care unit stay were significantly longer in the AFLP group than in the HELLP syndrome group [days: 17.00 (11.00, 25.00) vs. 9.00 (7.00, 12.00), 12.00 (4.00, 22.00) vs. 3.91 (0, 7.00), both P < 0.01]. Two AFLP patients died, including one due to intracranial venous thrombosis and one due to multiple organ failure and cardiopulmonary arrest. There were no deaths in the HELLP syndrome group.

CONCLUSIONS: There are significant differences in maternal characteristics, laboratory results and complications between AFLP and HELLP syndrome. TBil, γ-GGT, SCr, FIB, INR and AT III activity may help to distinguish the two diseases.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Dai D, Tang S, Xu W, et al. [A comparison of clinical characteristics between acute fatty liver of pregnancy and hemolysis, elevated liver enzymes and low platelets syndrome]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35924519. doi:10.3760/cma.j.cn121430-20220411-00361

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。